{"id":252870,"date":"2026-09-17T13:25:44","date_gmt":"2026-09-17T07:55:44","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=252870"},"modified":"2026-09-17T13:25:44","modified_gmt":"2026-09-17T07:55:44","slug":"why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/","title":{"rendered":"Astrazeneca Pharma India Ltd. (ASTRAZEN): Astrazeneca Pharma India Share Price near 52-week low: what the latest move means"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN)<\/a> share price is trading within 2% of its 52-week low of Rs 6,680 today and later stood at Rs 6,707.45, down 0.05% from the previous close. Market cap was Rs 16,777 crore.<\/em><\/div>\n<p style=\"margin-top:0!important;\">Astrazeneca Pharma India Share Price opened, traded and closed with little change on 17 September 2026, leaving Astrazeneca Pharma India Ltd. (ASTRAZEN) close to its 52-week low. The stock was last seen at Rs 6,707.45, down Rs 3.35 or 0.05%, with market capitalisation of Rs 16,777 crore. This Astrazeneca Pharma India Share Price update matters because the session kept the stock in the yearly-low zone even though the move was small. The supplied data confirms the price event but does not establish a company-specific catalyst, so the focus stays on the measurable market response, valuation backdrop and sector positioning that are driving Astrazeneca Pharma India Stock News and Astrazeneca Pharma India Share Price Today searches.<\/p>\n<p>For investors tracking Astrazeneca Pharma India Share Price live, the key question is not only why the stock is under pressure, but also whether the current price action and premium valuation can coexist with the company\u2019s earnings quality. Univest\u2019s AI research note looks at the stock from a market, technical, fundamental and sector lens, using only verified data.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Share_Price_Today_Price_Action_Analysis\" title=\"Astrazeneca Pharma India Share Price Today: Price Action Analysis\">Astrazeneca Pharma India Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\" title=\"Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis\">Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Why_Investors_Are_Watching_Astrazeneca_Pharma_India\" title=\"Why Investors Are Watching Astrazeneca Pharma India\">Why Investors Are Watching Astrazeneca Pharma India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#About_Astrazeneca_Pharma_India\" title=\"About Astrazeneca Pharma India\">About Astrazeneca Pharma India<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Track_Astrazeneca_Pharma_India_Share_Price_on_Univest\" title=\"Track Astrazeneca Pharma India Share Price on Univest\">Track Astrazeneca Pharma India Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Why_is_Astrazeneca_Pharma_India_Share_Price_near_a_52-week_low\" title=\"Why is Astrazeneca Pharma India Share Price near a 52-week low?\">Why is Astrazeneca Pharma India Share Price near a 52-week low?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_is_Astrazeneca_Pharma_India_Share_Price_today\" title=\"What is Astrazeneca Pharma India Share Price today?\">What is Astrazeneca Pharma India Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_does_Astrazeneca_Pharma_India_Share_Price_say_about_market_sentiment\" title=\"What does Astrazeneca Pharma India Share Price say about market sentiment?\">What does Astrazeneca Pharma India Share Price say about market sentiment?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Is_Astrazeneca_Pharma_India_Share_Price_expensive\" title=\"Is Astrazeneca Pharma India Share Price expensive?\">Is Astrazeneca Pharma India Share Price expensive?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#How_strong_are_Astrazeneca_Pharma_India_fundamentals\" title=\"How strong are Astrazeneca Pharma India fundamentals?\">How strong are Astrazeneca Pharma India fundamentals?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_does_the_sector_comparison_show_for_Astrazeneca_Pharma_India_Share_Price\" title=\"What does the sector comparison show for Astrazeneca Pharma India Share Price?\">What does the sector comparison show for Astrazeneca Pharma India Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#How_does_Astrazeneca_Pharma_India_compare_with_peers\" title=\"How does Astrazeneca Pharma India compare with peers?\">How does Astrazeneca Pharma India compare with peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_is_the_market_capitalisation_of_Astrazeneca_Pharma_India\" title=\"What is the market capitalisation of Astrazeneca Pharma India?\">What is the market capitalisation of Astrazeneca Pharma India?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#What_should_investors_monitor_next_in_Astrazeneca_Pharma_India_Share_Price\" title=\"What should investors monitor next in Astrazeneca Pharma India Share Price?\">What should investors monitor next in Astrazeneca Pharma India Share Price?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-astrazeneca-pharma-india-ltd-share-price-near-52-week-low-today-2026\/#Can_Astrazeneca_Pharma_India_Share_Price_be_tracked_on_Univest\" title=\"Can Astrazeneca Pharma India Share Price be tracked on Univest?\">Can Astrazeneca Pharma India Share Price be tracked on Univest?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Astrazeneca Pharma India Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,707.45<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,710.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs -3.35 (-0.05%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,710.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,719.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,680<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,777 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) traded at Rs 6,707.45 versus the previous close of Rs 6,710.8, a fall of 0.05%. The stock opened at Rs 6,710.8, reached a high of Rs 6,719.9, touched a low of Rs 6,680.<\/p>\n<p>Astrazeneca Pharma India Share Price Today shows a narrow session: the stock opened at Rs 6,710.80, matched the previous close at Rs 6,710.80, touched an intraday high of Rs 6,719.90 and a low of Rs 6,680. The day ended at Rs 6,707.45, leaving a decline of Rs 3.35 or 0.05%. Turnover stood at Rs 0.06 crore, while market capitalisation remained Rs 16,777 crore. This is a low-volatility session in absolute price terms, but it still keeps Astrazeneca Pharma India Share Price near its 52-week low and in the wider discussion of Stocks in News, Top Losers Today and Stocks at 52 Week Low.<\/p>\n<p>The price action indicates that selling pressure was present, even if the move was modest. Because the stock is trading close to a one-year low, the current Astrazeneca Pharma India Share Price structure is drawing attention from traders who monitor support levels and Price Action closely. The session confirms why Astrazeneca Pharma India Share Price News is being searched alongside Astrazeneca Pharma India Stock Performance and Astrazeneca Pharma India Share Price Update.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Fundamental_Analysis\"><\/span><strong>Astrazeneca Pharma India Ltd. (ASTRAZEN) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,777 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">98.91x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 361.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.54%<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) fundamental metrics show P\/E 98.91x, P\/B 18.55x, ROE 23.02%, ROCE 31.24%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. has a market capitalisation of Rs 16777 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 98.91x, P\/B at 18.55x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 23.02% and ROCE of 31.24%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 67.85, book value per share of Rs 361.68, dividend yield of 0.54%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 28.1x, median ROE of 11.7%, median ROCE of 13.61%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">98.91x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.1x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.11x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 661.74x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">18.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.92x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">23.02%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.7%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">31.24%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.61%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 16,777 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 730.86 crore<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 98.91x, which is above the benchmark median of 28.1x, a difference of +251.99%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROE of 23.02%, which is above the benchmark median of 11.7%, a difference of +96.75%. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a ROCE of 31.24%, which is above the benchmark median of 13.61%, a difference of +129.54%.<\/p>\n<p>Track stocks falling to yearly lows through the <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/alivus\/glenmark-life-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Glenmark Life Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ALIVUS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,837.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.41<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">24.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cohance\/suven-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Suven Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">COHANCE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,206.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">156.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.12<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aplltd\/alembic-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Alembic Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">APLLTD<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,193.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.37<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.35<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.74<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/jublpharma\/jubilant-pharmova-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Jubilant Pharmova Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">JUBLPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16,081.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.24<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">8.69<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/shilpamed\/shilpa-medicare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Shilpa Medicare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SHILPAMED<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17,834.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">61.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.43<\/td>\n<\/tr>\n<\/table>\n<p>Astrazeneca Pharma India Ltd. (ASTRAZEN) has a P\/E ratio of 98.91x compared with the displayed peer median of 45.36x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 23.02% compares with a peer median of 9.82% across the companies shown in the table. ROCE stood at 31.24% versus the displayed peer median of 11.43%, providing a capital-efficiency comparison. Astrazeneca Pharma India Ltd. (ASTRAZEN) has a market capitalisation of Rs 16,777 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Astrazeneca_Pharma_India\"><\/span><strong>Why Investors Are Watching Astrazeneca Pharma India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Astrazeneca Pharma India Share Price is near its 52-week low, keeping the stock in focus for Share Market Today screens.<\/li>\n<li>The session was flat-to-weak, with price action showing only a small decline but continued proximity to the yearly low.<\/li>\n<li>Astrazeneca Pharma India Fundamental Analysis shows strong ROE, ROCE and EPS, but a premium P\/E and P\/B.<\/li>\n<li>The healthcare sector benchmark suggests the stock trades at a much higher valuation than the same-industry median.<\/li>\n<li>Peer Comparison shows better profitability than several listed peers, which keeps Astrazeneca Pharma India Stock News relevant.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Astrazeneca_Pharma_India\"><\/span><strong>About Astrazeneca Pharma India<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Astrazeneca Pharma India Ltd. operates in Pharmaceuticals &amp; Drugs within the Healthcare sector. The business profile places it among established listed pharma names tracked on NSE and BSE, with a market capitalisation of Rs 16,777 crore. Based on the supplied financial data, the company has delivered revenue growth across the recent quarters, with turnover rising to Rs 6,827.9 crore in Jun 2026 from Rs 5,263.1 crore in Jun 2025. Profit has been more variable, which is visible in the quarterly net profit series.<\/p>\n<p>For investors studying Astrazeneca Pharma India Share Price Today, the company\u2019s profile matters because it combines premium valuation with solid profitability ratios. The supplied data also shows EPS of Rs 67.85 and book value of Rs 361.68, which help frame Astrazeneca Pharma India Share Price in a broader financial context. This makes the stock a frequent name in Astrazeneca Pharma India Latest News and Astrazeneca Pharma India Company News coverage.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Astrazeneca_Pharma_India_Share_Price_on_Univest\"><\/span><strong>Track Astrazeneca Pharma India Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/astrazen\/astrazeneca-pharma-india-ltd-share-price-today\">Astrazeneca Pharma India Ltd. (ASTRAZEN) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-low\">Univest 52-week-low screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-low lists and related market analysis.<\/p>\n<p>Investors can track Astrazeneca Pharma India Share Price on Univest for live price updates, technical indicators, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest combines stock analysis, sector context and peer comparison in one place so readers can follow Astrazeneca Pharma India Share Price Today, Astrazeneca Pharma India Stock News and Astrazeneca Pharma India Share Price Live without switching between multiple dashboards.<\/p>\n<p>The platform also helps users monitor Astrazeneca Pharma India Stock Performance, Astrazeneca Pharma India Latest News and Astrazeneca Pharma India Share News alongside broader healthcare market updates. For a stock trading near a 52-week low, that combined view can be useful for keeping the price action, valuation and company context in one editorial flow.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Astrazeneca_Pharma_India_Share_Price_near_a_52-week_low\"><\/span><strong>Why is Astrazeneca Pharma India Share Price near a 52-week low?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest session kept Astrazeneca Pharma India Share Price close to its 52-week low after a small decline. The data confirms the price event, but it does not establish a company-specific catalyst for the move.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Astrazeneca_Pharma_India_Share_Price_today\"><\/span><strong>What is Astrazeneca Pharma India Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price was Rs 6,707.45, down Rs 3.35 or 0.05% on the session. The stock opened at Rs 6,710.80 and ended very close to the previous close.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_Astrazeneca_Pharma_India_Share_Price_say_about_market_sentiment\"><\/span><strong>What does Astrazeneca Pharma India Share Price say about market sentiment?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The price action suggests cautious sentiment. The move was small, but the stock stayed near its yearly low, which keeps Astrazeneca Pharma India Share Price in focus for traders watching support and selling pressure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Astrazeneca_Pharma_India_Share_Price_expensive\"><\/span><strong>Is Astrazeneca Pharma India Share Price expensive?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On the supplied numbers, Astrazeneca Pharma India Share Price trades at a P\/E of 98.91 and P\/B of 18.55. Those multiples are well above the same-industry benchmark median and average.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_strong_are_Astrazeneca_Pharma_India_fundamentals\"><\/span><strong>How strong are Astrazeneca Pharma India fundamentals?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Fundamental Analysis shows ROE of 23.02%, ROCE of 31.24%, EPS of Rs 67.85 and book value of Rs 361.68. These figures indicate strong profitability relative to peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_the_sector_comparison_show_for_Astrazeneca_Pharma_India_Share_Price\"><\/span><strong>What does the sector comparison show for Astrazeneca Pharma India Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s P\/E, P\/B, ROE and ROCE all stand above the same-industry median or average. That makes Astrazeneca Pharma India Share Price a premium-valued pharma name in the healthcare universe.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Astrazeneca_Pharma_India_compare_with_peers\"><\/span><strong>How does Astrazeneca Pharma India compare with peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price carries richer valuation multiples than Glenmark Life Sciences, Alembic Pharmaceuticals, Jubilant Pharmova, Shilpa Medicare and Eris Lifesciences, while showing stronger ROE and ROCE than most of them.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Astrazeneca_Pharma_India\"><\/span><strong>What is the market capitalisation of Astrazeneca Pharma India?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Astrazeneca Pharma India Share Price corresponds to a market capitalisation of Rs 16,777 crore. That places the company above the same-industry median and close to the peer cluster provided in the dataset.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_next_in_Astrazeneca_Pharma_India_Share_Price\"><\/span><strong>What should investors monitor next in Astrazeneca Pharma India Share Price?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors may monitor price action around the yearly low, quarterly revenue and profit trends, and the valuation gap versus sector benchmarks. Univest tracks these elements together for a fuller stock view.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Can_Astrazeneca_Pharma_India_Share_Price_be_tracked_on_Univest\"><\/span><strong>Can Astrazeneca Pharma India Share Price be tracked on Univest?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes. Univest provides Astrazeneca Pharma India Share Price updates alongside live price, key ratios, shareholding pattern, 52-week levels and sector context, helping readers follow the stock in one place. The stock moved -0.05% during the session.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Astrazeneca Pharma India Ltd. Share Price trades near its 52-week low at Rs 6,707.45, marking a 0.05% decline today. Market cap stands at Rs 16,777 crore.<\/p>\n","protected":false},"author":29,"featured_media":252869,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-252870","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["252869"],"rank_math_title":["Astrazeneca Pharma India Share Price: price action and low"],"rank_math_description":["Astrazeneca Pharma India Share Price trades near its 52-week low. Read price action, valuation, fundamentals, sector context and peer comparison."],"rank_math_focus_keyword":["Astrazeneca Pharma India Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/Astrazeneca_Pharma_India_Ltd_ASTRAZEN_Astrazeneca_Pharma_India_Share_Price_near_52_week_low_what_the_latest_move_means_bearish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=252870"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252870\/revisions"}],"predecessor-version":[{"id":252871,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/252870\/revisions\/252871"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/252869"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=252870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=252870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=252870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}